In Friday’s Wall Street session, Medical Properties Trust Inc (NYSE:MPW) shares traded at $5.28, up 2.13% from the previous session.
MPW stock price is now -2.98% away from the 50-day moving average and 9.09% away from the 200-day moving average. The market capitalization of the company currently stands at $3.17B.
With the price target enhanced from $5 to $9, Exane BNP Paribas Upgraded its rating from Neutral to Outperform for Medical Properties Trust Inc (NYSE: MPW). On September 13, 2024, Colliers Securities Upgraded its previous ‘Neutral’ rating to ‘Buy’ on the stock keeping its target price maintained at $6.50, while ‘Exane BNP Paribas’ rates the stock as ‘Neutral’
In other news, Hanna James Kevin, Senior VP, Controller & CAO bought 7,411 shares of the company’s stock on Mar 05 ’25. The stock was bought for $42,613 at an average price of $5.75. Upon completion of the transaction, the Senior VP, Controller & CAO now directly owns 372,338 shares in the company, valued at $1.97 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 26 ’24, Senior VP, Controller & CAO Hanna James Kevin sold 11,641 shares of the business’s stock. A total of $43,305 was realized by selling the stock at an average price of $3.72. This leaves the insider owning 366,913 shares of the company worth $1.94 million. A total of 17.69% of the company’s stock is owned by insiders.
During the past 12 months, Medical Properties Trust Inc has had a low of $3.51 and a high of $6.55. The fifty day moving average price for MPW is $5.442 and a two-hundred day moving average price translates $4.84015 for the stock.
The latest earnings results from Medical Properties Trust Inc (NYSE: MPW) was released for 2024-12-31. The net profit margin was -242.20% and return on equity was -38.69% for MPW. The company reported revenue of $231.84 million for the quarter, compared to -$122.38 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -289.44 percent.
